The Cuban drug known so far as CIGB-300 is showing “very encouraging” results against COVID-19 in its first phase of clinical evaluation, according to the official media. The antiviral-action drug was designed by the Center for Genetic Engineering and Biotechnology (CIGB) in Havana, and is being studied as part of the research being carried out … Continue reading New Cuban drug with “very encouraging” results against COVID-19